| Serum phosphate and mortality in patients with chronic kidney disease H Eddington, R Hoefield, S Sinha, C Chrysochou, B Lane, RN Foley, ... Clinical Journal of the American Society of Nephrology 5 (12), 2251-2257, 2010 | 328 | 2010 |
| High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization J Ritchie, D Green, C Chrysochou, N Chalmers, RN Foley, PA Kalra American journal of kidney diseases 63 (2), 186-197, 2014 | 223 | 2014 |
| Dispelling the myth: the use of renin–angiotensin blockade in atheromatous renovascular disease C Chrysochou, RN Foley, JF Young, K Khavandi, CM Cheung, PA Kalra Nephrology Dialysis Transplantation 27 (4), 1403-1409, 2012 | 135 | 2012 |
| Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 133 | 2023 |
| Epidemiology and natural history of atherosclerotic renovascular disease C Chrysochou, PA Kalra Progress in cardiovascular diseases 52 (3), 184-195, 2009 | 123 | 2009 |
| The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease PA Kalra, C Chrysochou, D Green, CM Cheung, K Khavandi, S Sixt, ... Catheterization and Cardiovascular Interventions 75 (1), 1-10, 2010 | 121 | 2010 |
| Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 90 | 2023 |
| Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging C Chrysochou, A Power, AE Shurrab, S Husain, S Moser, J Lay, ... Clinical Journal of the American Society of Nephrology 5 (3), 484-489, 2010 | 83 | 2010 |
| BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease C Chrysochou, IA Mendichovszky, DL Buckley, CM Cheung, A Jackson, ... Nephrology Dialysis Transplantation 27 (3), 1013-1019, 2012 | 80 | 2012 |
| Gadolinium‐enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience C Chrysochou, DL Buckley, P Dark, A Cowie, PA Kalra Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 70 | 2009 |
| Frontiers in hemodialysis: Innovations and technological advances. C Basile, A Davenport, S Mitra, A Pal, D Stamatialis, C Chrysochou, ... Artificial organs 45 (2), 2021 | 53 | 2021 |
| The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features D Vassallo, J Ritchie, D Green, C Chrysochou, PA Kalra Nephrology Dialysis Transplantation 33 (3), 497-506, 2018 | 53 | 2018 |
| Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study SW Lim, C Chrysochou, DL Buckley, PA Kalra, SP Sourbron American Journal of Physiology-Renal Physiology 305 (5), F672-F678, 2013 | 47 | 2013 |
| Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis CM Cheung, C Chrysochou, AE Shurrab, DL Buckley, A Cowie, PA Kalra Nephrology Dialysis Transplantation 25 (4), 1133-1140, 2010 | 47 | 2010 |
| Current management of atherosclerotic renovascular disease–what have we learned from ASTRAL? C Chrysochou, PA Kalra Nephron Clinical Practice 115 (1), c73-c81, 2010 | 40 | 2010 |
| Anuric acute renal failure and pulmonary oedema: a case for urgent action C Chrysochou, S Sinha, N Chalmers, PR Kalra, PA Kalra International journal of cardiology 132 (1), e31-e33, 2009 | 40 | 2009 |
| Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD) C Chrysochou, CM Cheung, M Durow, RJ Middleton, LR Solomon, ... QJM: An International Journal of Medicine 102 (4), 283-288, 2009 | 35 | 2009 |
| Phenylketonuria, co‐morbidity, and ageing: a review ERLC Vardy, A MacDonald, S Ford, DL Hofman Journal of inherited metabolic disease 43 (2), 167-178, 2020 | 31 | 2020 |
| Kidney volume to GFR ratio predicts functional improvement after revascularization in atheromatous renal artery stenosis C Chrysochou, D Green, J Ritchie, DL Buckley, PA Kalra PLoS One 12 (6), e0177178, 2017 | 31 | 2017 |
| Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study C Chrysochou, H Randhawa, R Reeve, S Waldek, GN Wood, ... QJM: an international journal of medicine 101 (4), 313-316, 2008 | 31 | 2008 |
